Search results
Open to inorganic opportunities in specialty drugs, says Sun Pharma
Business Standard India· 1 hour agoSun Pharma has net cash position of $2.4 bn at end of FY24; 6 new specialty products in R&D pipeline
Sun Pharma has net cash position of $2.4 bn at end of FY24; 6 new specialty products in R&D pipeline